Benitec Biopharma
BNTC
BNTC
12 hedge funds and large institutions have $3.84M invested in Benitec Biopharma in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$631K | |
| 2 | +$572K | |
| 3 | +$480K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$210K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$21.7K |
Top Sellers
| 1 | -$17.8K | |
| 2 | -$13K | |
| 3 | -$9.21K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$5.11K |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$3.14K |